About MSHO

Sponsors

Emerging Sponsor

Champion Sponsor

Supporting Sponsor

Champion Sponsor

Champion Sponsor

Champion Sponsor

Supporting Sponsor

Champion Sponsor

Premier Sponsor

Premier Plus Sponsor

Champion Sponsor

Champion Sponsor

Supporting Sponsor

Agios Pharmaceuticals

Supporting Sponsor

Emerging Sponsor

Supporting Sponsor

Champion Sponsor

Coherus Biosciences

Champion Sponsor

Emerging Sponsor

Emerging Sponsor

Champion Sponsor

Supporting Sponsor

Champion Sponsor

Champion Sponsor

Champion Sponsor

Premier Plus Sponsor

Champion Sponsor

Premier Sponsor

Premier Plus Sponsor

Premier Sponsor

Premier Plus Sponsor

Oncology Supply

Premier Sponsor

Premier Sponsor

Premier Plus Sponsor

Premier Plus Sponsor

Champion Sponsor

Premier Sponsor

Supporting Sponsor

Premier Sponsor

Premier Plus Sponsor

Champion Sponsor

Premier Sponsor

Champion Sponsor

Pharmacy Advantage

Supporting Sponsor

Champion Sponsor

Seattle Genetics

Champion Sponsor

Supporting Sponsor

Premier Sponsor

Premier Sponsor

Premier Sponsor

view all sponsors

Advocacy

MSHO continuously contacts legislators, provides comments to policy makers and collaborates with payers on issues of concern to those delivering care to cancer patients.

Education

It is important that our members are aware of meetings, web casts, and other educational opportunities specifically designed to address the complexities of cancer care.

Research

MSHO is committed to furthering the advancement of cancer care by supporting the many organizations that provide cancer clinical trials to Michigan’s cancer patients.

Latest News

Michigan Medicaid Health Plan Common Formulary Comments Due May 17th

Nominations for the 2019 ASH Advocacy Leadership Institute Now Open

ASH is now accepting nominations for the 2019 ASH Advocacy Leadership Institute taking place October 21-22, in Washington, DC

CDC Clarifies Opioid Prescribing Guideline

Clinicians who prescribe opioids to control chronic pain in cancer patients, palliative care, and end-of-life care should follow recommendations of clinical practice guidelines

CMS Open Payments: Review and Dispute for Physicians and Teaching Hospitals

U.S. physicians have from April 1 until May 15 to review and dispute Open Payments data before it is made public on June 30

Patients, Doctors, Providers say Health Can't Wait

Prior authorization red tape and step therapy delays care and treatment for Michigan patients

Fact Sheet: 2019 Merit-based Incentive Payment System (MIPS) Payment Adjustments based on 2017 MIPS Scores

Medicare Part B Resources

Review ACCCs Medicare Part B Slide Deck Here